Ken Griffin Eyenovia, Inc. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.46 - $1.44 $2,024 - $6,336	-4,400 Reduced 62.86%	2,600 $1,000
Q2 2024 Aug 14, 2024	SELL	$0.52 - $1.06 $1,092 - $2,226	-2,100 Reduced 23.08%	7,000 $4,000
Q1 2024 May 15, 2024	BUY	$0.99 - $2.37 $7,920 - $18,960	8,000 Added 727.27%	9,100 $9,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $2.08 $9,936 - $19,136	-9,200 Reduced 89.32%	1,100 $2,000
Q3 2023 Nov 14, 2023	SELL	$1.57 - $2.54 $8,635 - $13,970	-5,500 Reduced 34.81%	10,300 $17,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $5.75 $34,918 - $90,850	15,800 New	15,800 $37,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.